» Articles » PMID: 20624306

Community Perceptions of Malaria and Malaria Treatment Behaviour in a Rural District of Ghana: Implications for Artemisinin Combination Therapy

Abstract

Background: Artesunate-amodiaquine (AS-AQ) was introduced in Ghana as the first line drug for treatment of uncomplicated malaria in 2004. We report the perceptions of malaria and malaria treatment behaviour, the community awareness of and perceptions about AS-AQ two years after the introduction of this ACT treatment for malaria.

Methods: Two surveys were conducted; a cross-sectional survey of 729 randomly selected household heads (urban-362, rural-367) and 282 women with children < 5 years (urban-121, rural-161) was conducted in 2006. A district wide survey was conducted in 2007 to assess awareness of AS-AQ. These were complemented with twenty-eight focus group discussions (FGDs) and 16 key informant interviews (KII) among community members and major stakeholders in the health care delivery services. All nine (9) health facilities and five (5) purposively selected drug stores were audited in order to identify commonly used anti-malarials in the study area at the time of the survey.

Results: Majority of respondents ( > 75%) in the sampled survey mentioned mosquito bites as the cause of malaria. Other causes mentioned include environmental factors (e.g. dirty surroundings) and standing in the sun. Close to 60% of the household heads and 40% of the care-givers interviewed did not know about AS-AQ. The community respondents who knew about and had ever taken AS-AQ perceived it to be a good drug; although they mentioned they had experienced some side effects including headaches and body weakness. Co-blistered AS-AQ was available in all the government health facilities in the study area. Different formulations of ACTs were however found in urban chemical shops but not in rural chemical stores where monotherapy antimalarials were predominant.

Conclusion: The knowledge of fever as a symptom of malaria is high among the study population. The awareness of AS-AQ therapy and its side-effect was low in the study area. Community education and sensitization, targeting all categories of the population, has to be intensified to ensure an efficient implementation process.

Citing Articles

Experience of healthcare personnel on Co-payment mechanism and the implications on its use in private drug outlets in Uganda.

Ocan M, Bakubi R, Nakalembe L, Ekusai-Sebatta D, Sam N PLoS One. 2024; 19(5):e0297416.

PMID: 38758832 PMC: 11101086. DOI: 10.1371/journal.pone.0297416.


Knowledge and practices of private pharmacy auxiliaries on malaria in Abidjan, Côte d'Ivoire.

Bedia-Tanoh V, Angora E, Miezan S, Kone-Bravo E, Konate-Toure A, Bosson-Vanga H Malar J. 2023; 22(1):330.

PMID: 37919734 PMC: 10623852. DOI: 10.1186/s12936-023-04751-8.


Community-Based Malaria Testing Reduces Polypharmacy in a Population-Based Survey of Febrile Illness in Western Kenya.

Laktabai J, Platt A, Turner E, Saran I, Kipkoech J, Menya D Int J Public Health. 2022; 67:1604826.

PMID: 36090831 PMC: 9453644. DOI: 10.3389/ijph.2022.1604826.


Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso.

Hien D, Kabore J, Siribie M, Soulama I, Barry N, Baguiya A Malar J. 2022; 21(1):202.

PMID: 35761273 PMC: 9235275. DOI: 10.1186/s12936-022-04225-3.


Rural-Urban Differentials in Access to Behaviour Change Communication and Use of Long-Lasting Insecticide-Treated Nets and Artemisinin-Based Combination Therapy in Southeast Nigeria.

Nwachukwu C, Anorue L, Ajaero I Ethiop J Health Sci. 2022; 32(1):55-64.

PMID: 35250217 PMC: 8864383. DOI: 10.4314/ejhs.v32i1.7.


References
1.
Gerstl S, Cohuet S, Edoh K, Brasher C, Lesage A, Guthmann J . Community coverage of an antimalarial combination of artesunate and amodiaquine in Makamba Province, Burundi, nine months after its introduction. Malar J. 2007; 6:94. PMC: 1948001. DOI: 10.1186/1475-2875-6-94. View

2.
Phillips-Howard P, Wannemuehler K, Kuile F, Hawley W, Kolczak M, Odhacha A . Diagnostic and prescribing practices in peripheral health facilities in rural western Kenya. Am J Trop Med Hyg. 2003; 68(4 Suppl):44-9. View

3.
Owusu-Agyei S, Asante K, Adjuik M, Adjei G, Awini E, Adams M . Epidemiology of malaria in the forest-savanna transitional zone of Ghana. Malar J. 2009; 8:220. PMC: 2765449. DOI: 10.1186/1475-2875-8-220. View

4.
Murphy S, Breman J . Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg. 2001; 64(1-2 Suppl):57-67. DOI: 10.4269/ajtmh.2001.64.57. View

5.
Quashie N, Duah N, Abuaku B, Koram K . The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs. Ann Trop Med Parasitol. 2007; 101(5):391-8. DOI: 10.1179/136485907X176553. View